GLMD

Galmed Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0081 2.77% 0.30 08:05:48
Open Price Low Price High Price Close Price Prev Close
0.2919
more quote information »

Recent News

Date Time Source Heading
12/01/20228:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Launches Its iHEAR Brand of OTC Hearing Aids on CVS.com
12/01/20227:59IHNWFeaturedAduro Announces Completion of Mechanical Assembly of its R2 Plastic Reactor
11/17/202206:25TRMNH.C. Wainwright Remains a Hold on Galmed Pharmaceuticals..
11/16/202217:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/08/202206:25TRMNH.C. Wainwright Keeps Their Hold Rating on Galmed..
8/04/202208:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/04/202208:00PRNUSGalmed Pharmaceuticals Provides Business Update and Reports..
7/07/202208:48EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/07/202208:27PRNUSGalmed Reports Significant Anti-Fibrotic Effects of Aramchol..
7/01/202216:31EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/22/202217:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/17/202216:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/17/202216:15PRNUSGalmed Pharmaceuticals Announces Receipt of Nasdaq Minimum..
5/17/202209:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/17/202208:21EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/17/202208:00PRNUSGalmed Pharmaceuticals Reports First Quarter 2022 Financial..
5/17/202207:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/17/202207:30PRNUSGalmed updates business and clinical development strategy to..
5/04/202207:45TRMNMaxim Group Thinks Galmed Pharmaceuticals’ Stock is Going to..
5/02/202209:12EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
5/02/202207:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/02/202207:00PRNUSGalmed Pharmaceuticals Provides Business Update and Reports..
4/28/202208:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/28/202207:00PRNUSGalmed reports interim results from the Open-Label part of..
4/26/202208:30PRNUSGalmed Pharmaceuticals to Report Fourth Quarter and Year End..
2/14/202208:14EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202216:43EDGARAmended Statement of Ownership (sc 13g/a)
1/11/202208:31SEEKGalmed gains 5% after securing three new U.S. patents for..
1/11/202208:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/11/202207:30PRNUSGalmed Continues to Drive Innovation with Three New US..
1/10/202208:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/10/202207:30PRNUSGalmed announces positive results of Phase 1 study of..